Insights On Regulatory Compliance
-
Driving Continuous Improvement: Pushing Through The Barriers To Change
10/15/2024
Discover how continuous improvement drives efficiency in pharmaceutical manufacturing. Learn strategies to harmonize processes and reduce environmental impact in this thoughtful exploration.
-
Characterization And Impurity Profiling Of Combined Amylin And GLP-1 Analogs
7/29/2025
GLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics.
-
Revolutionizing Drug Discovery: The Rise Of Fashionable Models
6/6/2024
As a result of advancements in research technology, "fashionable models" such as organoids and organs-on-chips (OoCs) have been developed. Explore organoid and OoC technologies in detail.
-
The Roadmap To Asset Performance Management In Life Sciences
8/12/2025
Find out how asset performance management boosts reliability, compliance, and efficiency in life sciences, which guides organizations from reactive fixes to predictive optimization.
-
Do Not Bear Cross Contamination In The Pharmaceutical Industry – Prevent It
3/25/2025
Learn how thorough cleaning and process optimization in pharma manufacturing prevent cross-contamination, ensure product integrity, and enhance efficiency while also improving compliance and reducing costs.
-
Validating Pharma 4.0 For Smart Manufacturing
1/24/2025
Explore the digital evolution of manufacturing control and management, the building blocks of Pharma 4.0, and how the life sciences industry can realize the full potential of Pharma 4.0.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance
3/4/2025
It was imperative for a large European CMO that produces multiple biologic drugs to select the right product quality and value for each customer to comply with the August 2023 revision to the EU GMP Annex 1.
-
Time To Intensify: Taking mAb Manufacturing To The Next Level
8/19/2025
Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.
-
Revolutionizing Drug Manufacturing: A Closer Look At GMP Inspections
12/20/2023
Learn about the collaborative efforts among global regulators currently underway to address drug availability challenges following the supply shortages and disruptions from the COVID-19 pandemic.
-
Nitrosamine Analysis: Solutions For Risk Management And Analytical Testing
8/22/2024
Testing for nitrosamines is essential in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and drug products to ensure safety and compliance.